We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERN
176
DELISTED
Cerner Corp
CERN
| $97.1M | 0.12% |
1,696,584
-556,473
| -25% | -$31M |
|
177
Insulet
PODD
$11B
| $95.4M | 0.12% |
1,003,026
-302,529
| -23% | -$25.9M |
|
178
Monolithic Power Systems
MPWR
$69B
| $95.2M | 0.12% |
702,818
+9,475
| +1% | +$1.24M |
|
179
Martin Midstream Partners
MMLP
$95.1M
| $95.2M | 0.12% |
7,647,133
-113,627
| -1% | -$1.43M |
|
|
INFO
180
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $94.5M | 0.12% |
1,738,381
-102,710
| -6% | -$5.38M |
|
181
Planet Fitness
PLNT
$4.26B
| $93.8M | 0.12% |
1,365,027
+139,907
| +11% | +$8.48M |
|
|
NVRO
182
DELISTED
NEVRO CORP.
NVRO
| $93.8M | 0.12% |
1,500,000
| – | – |
|
|
CZR
183
DELISTED
Caesars Entertainment Corporation
CZR
| $93.6M | 0.12% |
10,771,758
+736,679
| +7% | +$6.39M |
|
184
Burlington
BURL
$22.3B
| $93.5M | 0.12% |
596,734
+117,803
| +25% | +$19M |
|
185
CrossAmerica Partners
CAPL
$841M
| $93.5M | 0.12% |
5,119,101
-24,017
| -0.5% | -$413K |
|
186
Pool Corp
POOL
$7.12B
| $93.4M | 0.12% |
566,190
+42,528
| +8% | +$6.6M |
|
|
OPLN
187
Openlane
OPLN
$4.19B
| $92.2M | 0.11% |
4,749,634
-3,407,610
| -42% | -$64.2M |
|
188
Sarepta Therapeutics
SRPT
$1.68B
| $91.6M | 0.11% |
768,868
+641,904
| +506% | +$82.5M |
|
189
Wabtec
WAB
$49.2B
| $91.3M | 0.11% |
1,239,113
+325,536
| +36% | +$23.5M |
|
190
IPG Photonics
IPGP
$4.18B
| $91.2M | 0.11% |
600,855
-197
| -0% | -$27.9K |
|
|
CLDR
191
DELISTED
Cloudera, Inc.
CLDR
| $89.9M | 0.11% |
8,220,000
+5,220,000
| +174% | +$67.1M |
|
|
CYBR
192
DELISTED
CyberArk
CYBR
| $87.5M | 0.11% |
735,302
+129,450
| +21% | +$12.4M |
|
193
Atlassian
TEAM
$21.6B
| $86.7M | 0.11% |
771,005
+1,969
| +0.3% | +$201K |
|
194
3D Systems Corp
DDD
$433M
| $86.4M | 0.11% |
8,033,544
+407
| +0% | +$4.84K |
|
195
HEICO Corp
HEI
$47.2B
| $86M | 0.11% |
906,485
-37,579
| -4% | -$3.28M |
|
|
COHR
196
DELISTED
Coherent Inc
COHR
| $85.5M | 0.11% |
603,278
-761
| -0.1% | -$96.3K |
|
197
LyondellBasell Industries
LYB
$20.2B
| $85.5M | 0.11% |
1,016,734
+971,651
| +2,155% | +$84M |
|
198
Lamar Advertising Co
LAMR
$16.1B
| $85.3M | 0.11% |
1,076,280
+65,992
| +7% | +$4.99M |
|
199
Entergy
ETR
$53.5B
| $85.2M | 0.11% |
1,781,548
-354,984
| -17% | -$16M |
|
|
ZEN
200
DELISTED
ZENDESK INC
ZEN
| $84.9M | 0.11% |
998,880
+47,137
| +5% | +$3.46M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.